Abstract
A new synthetic route to individual isomers of 4-chloro-17α-methylandrost-1,4-diene-3,17β-diol (halodrol, CDMA) based on reduction of the carbonyl group in dehydrochloromethyltestosterone (oral turinabol, DHCMT), followed by separation of epimers by fractional crystallisation from dichloromethane is presented. Reduction of the disubstituted double bond of the diene system in 3α-hydroxy isomer of halodrol afforded 4-chloro-17α-methyl-androst-4-ene-3α,17β-diol contained A-ring corresponding to 4-chloro-17β-hydroxymethyl-17α-methyl-18-norandrosta-4,13-dien-3α-ol (M4), which is one of the long-term metabolites of oral turinabol.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.